Related Experiment Video
Updated: May 29, 2026

Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
Published on: April 6, 2021
Aggregatibacter aphrophilus in a patient with recurrent empyema: a case report
Lasantha Ratnayake1, William J Olver, Tom Fardon
1Department of Medical Microbiology, Level 6, Ninewells Hospital, Dundee, DD1 9SY, UK. lratnayake@nhs.net.
Introduction:
Aggregatibacter aphrophilus (formerly Haemophilus aphrophilus and H. paraphrophilus) is classically associated with infective endocarditis. Other infections reported in the literature include brain abscess, bone and joint infections and endophthalmitis. There are only two cases of empyema ever reported due to this organism. We report the isolation of A. aphrophilus from pleural fluid on three separate hospital admissions in a patient with recurrent empyema.
Case Presentation:
A 65-year-old female patient of Caucasian origin presented with a three-week history of fever, shortness of breath and dry cough. She was found to have a pleural empyema so a chest drain was inserted and a sample of pus was sent to the microbiology laboratory. After overnight incubation, a chocolate blood agar plate incubated in 5% carbon dioxide showed a profuse growth of small, round, glistening colonies which were identified as Gram-negative coccobacilli. They were oxidase- and catalase-negative. Biochemical testing using RapID NH confirmed the identity of the organism as A. aphrophilus. It was susceptible to amoxicillin, levofloxacin and doxycycline. Our patient was treated with intravenous amoxicillin with clavulanic acid and clarithromycin followed by oral doxycycline, but was re-admitted twice over the next three months with recurrent empyema and the same organism was isolated. Each episode was managed with chest drainage and a six-week course of antibiotic--doxycycline for the second episode and amoxicillin for the third episode, after which she has remained well.
Conclusion:
This is the first case report of recurrent empyema due to A. aphrophilus. Our patient had no underlying condition to explain the recurrence. Although our isolate was doxycycline susceptible, our patient had recurrent infection after treatment with this antibiotic, suggesting that this antibiotic is ineffective in treatment of deep-seated A. aphrophilus infection. This organism can be difficult to identify in the laboratory because, unlike closely related Haemophilus spp., it is oxidase-negative, catalase-negative and X and V independent.
Insights
This case report details recurrent empyema caused by Aggregatibacter aphrophilus, a rare bacterial infection. Despite antibiotic treatment, the patient experienced multiple episodes, highlighting challenges in managing deep-seated infections with doxycycline.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Aggregatibacter aphrophilus is typically linked to infective endocarditis.
- Empyema is an uncommon manifestation of A. aphrophilus infections, with only two prior reported cases.
- This study presents a unique case of recurrent empyema due to A. aphrophilus.
Purpose of the Study:
- To report the first case of recurrent empyema caused by Aggregatibacter aphrophilus.
- To highlight the diagnostic challenges associated with A. aphrophilus.
- To discuss potential treatment ineffectiveness of certain antibiotics for deep-seated infections.
Main Methods:
- A 65-year-old female patient presented with recurrent empyema.
- Pleural fluid samples were collected and analyzed microbiologically.
- The causative organism, A. aphrophilus, was identified through biochemical testing.
- Patient treatment involved chest drainage and various antibiotic regimens.
Main Results:
- Aggregatibacter aphrophilus was isolated from pleural fluid during three separate admissions for recurrent empyema.
- The patient's isolate was susceptible to doxycycline in vitro.
- Recurrent infections occurred despite doxycycline treatment, suggesting its ineffectiveness in deep-seated disease.
Conclusions:
- This is the first reported case of recurrent empyema due to A. aphrophilus.
- The organism's unique biochemical profile (oxidase-negative, catalase-negative, X and V independent) can complicate laboratory identification.
- Doxycycline may be ineffective for treating deep-seated A. aphrophilus infections, even with in vitro susceptibility.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Atypical Pneumonia
Pneumonia I: Introduction
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...